John Munkhaugen

1.8k total citations
68 papers, 959 citations indexed

About

John Munkhaugen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, John Munkhaugen has authored 68 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 22 papers in Surgery and 15 papers in Economics and Econometrics. Recurrent topics in John Munkhaugen's work include Cardiac Health and Mental Health (24 papers), Lipoproteins and Cardiovascular Health (21 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). John Munkhaugen is often cited by papers focused on Cardiac Health and Mental Health (24 papers), Lipoproteins and Cardiovascular Health (21 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). John Munkhaugen collaborates with scholars based in Norway, Sweden and Denmark. John Munkhaugen's co-authors include Jan Erik Otterstad, Toril Dammen, Irene Sandven, Vidar Ruddox, Stian Lydersen, Stein Hallan, Tor‐Erik Widerøe, Thor Edvardsen, Torbjørn Moum and Lars Gullestad and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and PLoS Genetics.

In The Last Decade

John Munkhaugen

60 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Munkhaugen Norway 17 541 178 93 90 89 68 959
Allan J. Hsiao United Kingdom 11 999 1.8× 90 0.5× 192 2.1× 128 1.4× 96 1.1× 12 1.5k
Vicente Pallarés‐Carratalá Spain 19 764 1.4× 308 1.7× 111 1.2× 161 1.8× 147 1.7× 139 1.5k
Michael P. Bancks United States 21 392 0.7× 166 0.9× 260 2.8× 184 2.0× 32 0.4× 81 1.4k
Henrietta Mulnier United Kingdom 13 314 0.6× 230 1.3× 192 2.1× 107 1.2× 31 0.3× 21 1.4k
Amichai Perlman Israel 18 277 0.5× 111 0.6× 113 1.2× 130 1.4× 16 0.2× 34 1.0k
Elke Lehmkuhl Germany 19 531 1.0× 181 1.0× 190 2.0× 225 2.5× 32 0.4× 27 1.3k
Yu. V. Zhernakova Russia 13 448 0.8× 102 0.6× 282 3.0× 64 0.7× 20 0.2× 83 761
Theodore Feldman United States 18 469 0.9× 289 1.6× 252 2.7× 214 2.4× 73 0.8× 57 1.3k

Countries citing papers authored by John Munkhaugen

Since Specialization
Citations

This map shows the geographic impact of John Munkhaugen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Munkhaugen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Munkhaugen more than expected).

Fields of papers citing papers by John Munkhaugen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Munkhaugen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Munkhaugen. The network helps show where John Munkhaugen may publish in the future.

Co-authorship network of co-authors of John Munkhaugen

This figure shows the co-authorship network connecting the top 25 collaborators of John Munkhaugen. A scholar is included among the top collaborators of John Munkhaugen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Munkhaugen. John Munkhaugen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munkhaugen, John, et al.. (2026). The use of β-blockers after myocardial infarction: no doubts remain. Nature Reviews Cardiology. 23(3). 208–208.
2.
Weedon‐Fekjær, Harald, Marie Stugaard, Einar Husebye, et al.. (2025). Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial. Addiction. 121(4). 957–969.
3.
Andersen, Susan, Are Hugo Pripp, Harald Hrubos‐Strøm, et al.. (2025). The effects of cognitive behavioral therapy for insomnia in patients with cardiovascular disease: a systematic review and meta-analysis. Journal of Clinical Sleep Medicine. 21(7). 1273–1284. 1 indexed citations
4.
Munkhaugen, John, et al.. (2024). Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease. Clinical and Translational Science. 17(10). e70025–e70025. 1 indexed citations
5.
Atar, Dan, et al.. (2024). Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?. Kardiologia Polska. 82(9). 828–830. 1 indexed citations
6.
Halvorsen, Sigrun, et al.. (2024). Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. European Heart Journal - Quality of Care and Clinical Outcomes. 11(8). 1290–1300. 1 indexed citations
7.
Munkhaugen, John, et al.. (2023). Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease. European Journal of Preventive Cardiology. 30(Supplement_1).
8.
Munkhaugen, John, Harald Weedon‐Fekjær, Kari Peersen, et al.. (2023). Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease. Pharmacology Research & Perspectives. 11(3). e01089–e01089. 2 indexed citations
9.
Semb, Anne Grete, Elisabeth Kleivhaug Vesterbekkmo, Kjetil Retterstøl, et al.. (2023). PCSK9-hemmere på blå resept for hvem?. Tidsskrift for Den norske legeforening. 143(8). 1 indexed citations
10.
11.
Munkhaugen, John, et al.. (2023). Predictors of health-related quality of life in outpatients with coronary heart disease. Frontiers in Psychology. 14. 1119093–1119093. 2 indexed citations
12.
Rahman, Zillur, Shahram Bahrami, Guy Hindley, et al.. (2022). Shared genetic loci between depression and cardiometabolic traits. PLoS Genetics. 18(5). e1010161–e1010161. 29 indexed citations
13.
Bahrami, Shahram, Oleksandr Frei, Alexey Shadrin, et al.. (2021). Shared genetic architecture between neuroticism, coronary artery disease and cardiovascular risk factors. Translational Psychiatry. 11(1). 368–368. 9 indexed citations
14.
Otterstad, Jan Erik, Vidar Ruddox, Bjørn Bendz, et al.. (2021). Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction. International journal of cardiac imaging. 37(12). 3477–3487. 1 indexed citations
15.
Papageorgiou, Costas, et al.. (2021). Worry and rumination predict insomnia in patients with coronary heart disease: a cross-sectional study with long-term follow-up. Journal of Clinical Sleep Medicine. 18(3). 779–787. 17 indexed citations
16.
Munkhaugen, John, et al.. (2021). Insomnia in patients with coronary heart disease: prevalence and correlates. Journal of Clinical Sleep Medicine. 17(5). 931–938. 34 indexed citations
17.
Vethe, Nils Tore, Kari Peersen, Morten Wang Fagerland, et al.. (2020). Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial. European Heart Journal - Cardiovascular Pharmacotherapy. 7(6). 507–516. 19 indexed citations
18.
Peersen, Kari, Harald Weedon‐Fekjær, Joep Perk, et al.. (2020). Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population. BMC Cardiovascular Disorders. 20(1). 61–61. 15 indexed citations
19.
Ruddox, Vidar, et al.. (2017). Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. European Journal of Preventive Cardiology. 24(14). 1555–1566. 230 indexed citations
20.
Munkhaugen, John, Kari Peersen, Erik Gjertsen, et al.. (2015). The role of medical and psychosocial factors for unfavourable coronary risk factor control. Scandinavian Cardiovascular Journal. 50(1). 1–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan J. Hsiao Breakdown of academic impact, for papers by Vicente Pallarés‐Carratalá Breakdown of academic impact, for papers by Michael P. Bancks Breakdown of academic impact, for papers by Henrietta Mulnier Breakdown of academic impact, for papers by Amichai Perlman Breakdown of academic impact, for papers by Elke Lehmkuhl Breakdown of academic impact, for papers by Yu. V. Zhernakova Breakdown of academic impact, for papers by Theodore Feldman
Rankless by CCL
2026